DOP2005000068A - MORFOLINE COMPOUNDS REPLACED FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS - Google Patents

MORFOLINE COMPOUNDS REPLACED FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

Info

Publication number
DOP2005000068A
DOP2005000068A DO2005000068A DO2005000068A DOP2005000068A DO P2005000068 A DOP2005000068 A DO P2005000068A DO 2005000068 A DO2005000068 A DO 2005000068A DO 2005000068 A DO2005000068 A DO 2005000068A DO P2005000068 A DOP2005000068 A DO P2005000068A
Authority
DO
Dominican Republic
Prior art keywords
treatment
nervous system
central nervous
morfoline
system disorders
Prior art date
Application number
DO2005000068A
Other languages
Spanish (es)
Inventor
Nancy Sue Barta
Shelly Ann Glase
Gray David Lawrence Firman
Gregory Adan Reichard
Lloyd Jerome Simons
Wenjian Xu
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Priority to DO2005000068A priority Critical patent/DOP2005000068A/en
Publication of DOP2005000068A publication Critical patent/DOP2005000068A/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

La invención se refiere a compuestos de formulas I En las que R1-R8, A, X, y Z se definen como en la memoria descriptiva, a composiciones farmacéuticas que los contienen y a su uso en el tratamiento de trastornos del sistema nervioso central.The invention relates to compounds of formulas I in which R1-R8, A, X, and Z are defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of disorders of the central nervous system.

DO2005000068A 2005-04-27 2005-04-27 MORFOLINE COMPOUNDS REPLACED FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS DOP2005000068A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DO2005000068A DOP2005000068A (en) 2005-04-27 2005-04-27 MORFOLINE COMPOUNDS REPLACED FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DO2005000068A DOP2005000068A (en) 2005-04-27 2005-04-27 MORFOLINE COMPOUNDS REPLACED FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

Publications (1)

Publication Number Publication Date
DOP2005000068A true DOP2005000068A (en) 2005-12-15

Family

ID=44261471

Family Applications (1)

Application Number Title Priority Date Filing Date
DO2005000068A DOP2005000068A (en) 2005-04-27 2005-04-27 MORFOLINE COMPOUNDS REPLACED FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS

Country Status (1)

Country Link
DO (1) DOP2005000068A (en)

Similar Documents

Publication Publication Date Title
ECSP066962A (en) MORFOLINE COMPOUNDS REPLACED FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
ECSP066391A (en) [1,8] NAFTIRIDIN-2-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA
ECSP055676A (en) HETEROCYCLIC PIPERAZINAS REPLACED FOR THE TREATMENT OF CHICHOPHRENIA
GT200600159A (en) BENZODIOXAN AND BENZODIOXOLAN DERIVATIVES AND USES OF THE SAME
SV2010003662A (en) DERIVATIVES OF AZETIDINE AND CYCLLOBUTANE AS JAK INHIBITORS REF. X-19081
CO6331473A2 (en) DERIVATIVES OF 2,3-DIHYDROBENZO [1,4] DIOXIN-2-ILMETILO AS ALFA2C ANTAGONISTS FOR USE IN THE TREATMENT OF CENTRAL AND PERIPHERAL NERVOUS SYSTEM DISEASES
ECSP11011439A (en) SUBSTITUTED 1-CYANOETHYLETHYCLIC CARBOXAMIDE 750 COMPOUNDS
UY29781A1 (en) DIAZASPIRO SUBSTITUTE COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE COMPOUNDS OR SALTS, PREPARATION METHODS AND USES
PA8675701A1 (en) NEW DERIVATIVES OF FLUORENE, COMPOSITIONS THAT CONTAIN THEM AND ITS USE
UY29414A1 (en) PIRIMIDINE DERIVATIVES FOR THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS
UY30835A1 (en) 8-ALQUINILXANTINAS AND DERIVATIVES
CO6341617A2 (en) 5-ALQUINIL-PYRIMIDINS
CO6331434A2 (en) NEW COMPOUNDS
CR9407A (en) TETRAHYDROPIRIDOAZEPIN-8-ONAS AND RELATED COMPOUNDS FOR THE TREATMENT OF CHICHOPHRENIA
CO6460762A2 (en) 5-ALQUINIL-PIRIDINAS
CR7735A (en) HETEROCICLIC PIPERIZINES REPLACED FOR THE TREATMENT OF CHICHOPHRENIA
UY27998A1 (en) HETEROCYCLIC REPLACED SUBSTITUTED PIPERAZINES FOR THE TREATMENT OF CHICHOPHRENIA
UY31522A1 (en) NANOPARTICLES WITH MODIFIED SURFACE
UY31805A (en) AGONISTS M1, PHARMACEUTICAL COMPOSITIONS OF THE SAME, PROCESSES FOR THEIR PREPARATION AND ITS USES FOR THE TREATMENT OF PAIN
UY29052A1 (en) NEW INHIBITORS OF THE QUINOXALINONE NOREPINEFRINE RECOVERY FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEMS
DOP2005000068A (en) MORFOLINE COMPOUNDS REPLACED FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
NI201200103A (en) NEW DERIVATIVES (HETEROCICLO - TETRAHIDRO - PIRIDIN) - (PIPERAZINIL) - 1 - ALCANONE AND (HETEROCICLO - DIHIDRO - PIRROLIDIN) - (PIPERAZINIL) - 1 - ALCANONA AND ITS USE AS INHIBITORS OF p75
CO6592046A2 (en) 5-alkynyl pyrimides and their use as kinase inhibitors
ECSP11011464A (en) TIA-TRIAZA-CICLOPENTAZULENOS
DOP2005000151A (en) NEW INHIBITORS OF THE QUINOXALINONE NOREPINEFRINE RECAPTATION FOR THE TREATMENT OF THE CENTRAL NERVOUS SYSTEM.